Description

Lee, J. K., Bussey, K. J., Gwadry, F. G., Reinhold, W., Riddick, S. L. Pelletier, S. Nishizuka, G. Szakacs, J. Annereau, G., Shankavaram, U., Lababidi, S., Smith, L. H., Gottesman, M. M., and Weinstein, J. N., (2003) Comparing cDNA and oligonucleotide array data: Concor- dance of gene expression across platforms for the NCI- 60 cancer cells, Genome, Biol., 4, R82.

Okay, I need to create a blog post based on the provided quote from the Lee et al. 2003 study. The title is the quote itself, so I need to make sure the title is that exact quote. The user wants the content to be informative and engaging, around 300 words, with paragraph-structured content and natural SEO keywords.

First, I should understand what the study is about. The quote references a comparison between cDNA and oligonucleotide array data in the NCI-60 cancer cells. So the main points to cover are the importance of gene expression profiling, the two technologies compared (cDNA and oligonucleotide arrays), the concordance found between them, the significance of the NCI-60 cell line panel, and the implications for cancer research.

I need to start with an engaging introduction that explains why comparing gene expression data is important. Maybe mention how accurate gene expression data is crucial for understanding cancer. Then introduce the Lee et al. study. Next paragraphs can discuss the cDNA and oligonucleotide arrays, what they are, their differences, why comparing them matters. Then talk about the NCI-60 dataset and its role in cancer research. The study’s findings on concordance between the two platforms, the validation of data across platforms, and the implications for reliability and cross-validation. Also, mention the legacy of the study in modern research methods.

For SEO, keywords like “cDNA microarray data,” “oligonucleotide arrays,” “gene expression analysis,” “NCI-60 cancer cells,” “cancer research,” “concordance study,” “molecular data cross-validation” might be relevant. I need to ensure these terms are naturally integrated into the content.

I should check for any terms that need definition for non-experts, like explaining what cDNA and oligonucleotide arrays are, though maybe briefly. Make sure the content flows logically from introduction to study details, key findings, significance, and a conclusion.

Avoid technical jargon where possible, but since it’s about cancer research, some terms are necessary. The tone should be academic but accessible. Need to ensure that each paragraph is concise and addresses a specific point. Also, make sure the title is the exact quote, including all authors and publication details as given.

**Lee, J. K., Bussey, K. J., Gwadry, F. G., Reinhold, W., Riddick, S. L. Pelletier, S. Nishizuka, G. Szakacs, J. Annereau, G., Shankavaram, U., Lababidi, S., Smith, L. H., Gottesman, M. M., and Weinstein, J. N., (2003) Comparing cDNA and oligonucleotide array data: Concor- dance of gene expression across platforms for the NCI- 60 cancer cells, Genome, Biol., 4, R82**

In the rapidly evolving field of cancer research, the ability to accurately measure gene expression is critical for understanding tumor biology and developing targeted therapies. A landmark 2003 study by Lee et al. (Genome Biology, 4:R82) addressed a pivotal question in genomics: *How consistent are gene expression results when analyzed using different platforms?* Their comparison of cDNA microarrays and oligonucleotide arrays across the NCI-60 cancer cell collection remains a cornerstone in validating data reliability.

The NCI-60, a panel of 60 diverse human cancer cell lines, is a widely used resource for drug discovery and molecular profiling. At the time of the study, two primary technologies dominated gene expression analysis: **cDNA microarrays**, which use labeled cDNA fragments hybridized to immobilized probes, and **oligonucleotide arrays**, which rely on short synthetic DNA probes for detection. Both methods risk producing divergent data due to design differences, but Lee et al. sought to evaluate their concordance.

Their findings revealed a significant overlap in gene expression signatures between the two platforms. For the majority of genes, both cDNA and oligonucleotide arrays yielded consistent results, validating the NCI-60 dataset’s robustness. This concordance was particularly striking in oncogenes and tumor suppressor genes, which are central to cancer progression. By demonstrating cross-platform reliability, the study underscored the NCI-60’s value as a gold-standard reference for **cancer genomics**.

The implications of this work are profound. For researchers, it reinforces confidence in **cross-platform gene expression analysis**—a practice now essential for large-scale studies. The study also paved the way for integrating data from diverse genomics projects, fostering collaboration in **precision oncology**. Furthermore, it highlighted the importance of standardized protocols, ensuring reproducibility across labs.

Though newer technologies like RNA sequencing now exist, the Lee et al. study remains a benchmark. It reminds us that harmonizing **molecular data** across platforms is key to advancing cancer science. As the field moves toward personalized treatments, the reliability of foundational datasets like the NCI-60 will continue to guide discovery and innovation.

For a deeper dive into **gene expression comparisons** or to explore the NCI-60 dataset, consult bioinformatics tools and resources dedicated to **cancer research analytics**. Let this 2003 breakthrough inspire your next scientific inquiry—after all, consistency in data is the bedrock of groundbreaking insights.